The aesthetic rehabilitation of patients remains a challenge for practicians. To facilitate the clinicians’ and technicians’ task, several innovative methods were developed, like the diagnostic wax-up and mock-up. The width-to-length ratio of the maxillary frontal teeth can be used to evaluate dentofacial aesthetics. Our study presents the variations between the teeth size measured on casts obtained during the prosthodontic treatment.
Emese Rita Markovics, Kinga Jánosi, Carmen Biriș, Diana Cerghizan, C Horga, B Bögözi and Alina Iacob
Objective: The objective of our work is to examine the presence of the much-discussed golden proportion provided by Levin, and of the golden percentage (Snow), on the widths of maxillary anterior teeth, by measurements made on digital images.
Material and method: The material of this study consists of digital photographs taken of subjects with natural and esthetic teeth. We took photos of 68 subjects (35 women and 33 men), between 19 and 26 years. Using a computer program, we made the necesarry measurements, then we made the appropriate calculations of the above theories.
Results: The golden proportion between the lateral and central incisor occurs in a higher proportion than between the canine and the lateral incisor. The values obtained by analyzing the golden proportion differ slightly from those proposed by Snow.
Conclusions: The frequency of the golden proportion is not significant for the groups of teeth mentioned. With small modifications and taking into consideration ethnic differences, Snow's golden percentage is more valid and applicable than Levin's golden proportion is.
Ioana-Aurița Albu-Stan, Daniel-Emil Albu, Diana Cerghizan, Lia Yero Eremie, Kinga Jánosi, Monica Baloș and Constantin Copotoiu
Osteonecrosis of the jaws is a complication after treatment with antiresorptive drugs. Bisphosphonates (BPs) are widely used to treat conditions with bone metastases of malignant tumors such as multiple myeloma, breast cancer, prostatic cancer, as well as hypercalcemia of malignancy, osteoporosis, Paget’s disease, and osteogenesis imperfecta. Denosumab is an antiresorptive agent that is used for the treatment of osteoporosis or metastatic bone diseases. These antiresorptive agents improve the quality of life of patients by increasing strength and bone mineral density, and reducing the risk of bone fractures. More than a decade had passed since the first publication of this pathology, and the occurrence of the disease, its pathophysiology, and proper treatment methods are still not fully elucidated. Prevention is critical in medication-related osteonecrosis of the jaw, because the treatment is difficult, and there are no universally accepted treatment protocols. There is an accepted approach of palliation of symptoms and controlling the associated infections. Treatment may follow one of three procedures: conservative management of pain, conservative or extensive (segmental) surgery, depending on the disease stage.